Loading...

Redcare Pharmacy NV

RDC.DEXETRA
HealthcareMedical - Pharmaceuticals
98.55
-1.35(-1.35%)

Redcare Pharmacy NV RDC.DE Peers

See (RDC.DE) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
RDC.DE€98.55-1.35%2B-40.89-€2.41N/A
NOVC.DE€91.40-1.98%406.7B22.91€3.99N/A
4AB.DU€164.00-0.49%289.7BN/AN/A+3.22%
W8A.DE€9.85-0.11%8.5B-1.69-€5.84+5.81%
SAE.DE€88.30N/A1.6B-26.60-€3.32N/A
2LYA.F€2.04+0.74%165.1M-40.80-€0.05N/A
NP5.DE€7.86-0.88%156.9M9.25€0.85N/A
5EA.DE€19.20N/A0N/AN/AN/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

RDC.DE vs NOVC.DE Comparison

RDC.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RDC.DE stands at 2B. In comparison, NOVC.DE has a market cap of 406.7B. Regarding current trading prices, RDC.DE is priced at €98.55, while NOVC.DE trades at €91.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RDC.DE currently has a P/E ratio of -40.89, whereas NOVC.DE's P/E ratio is 22.91. In terms of profitability, RDC.DE's ROE is -0.09%, compared to NOVC.DE's ROE of +0.86%. Regarding short-term risk, RDC.DE is more volatile compared to NOVC.DE. This indicates potentially higher risk in terms of short-term price fluctuations for RDC.DE.

Stock Price Comparison

Loading...

Frequently Asked Questions